Wodwala woyamba kupatsidwa zotupa zapamwamba zolimba

A GWIRITSANI KwaulereKutulutsidwa 5 | eTurboNews | | eTN
Avatar ya Linda Hohnholz
Written by Linda Hohnholz

Jubilant Therapeutics Inc. lero yalengeza za kuyesedwa kwa wodwala woyamba muyeso lachipatala la Phase I/II la JBI-802 mwa odwala omwe ali ndi zotupa zolimba kwambiri. JBI-802 ndi yoyamba mu kalasi, kamolekyu yaying'ono, yoyendetsedwa pakamwa pawiri ya LSD1 ndi HDAC6 yomwe yawonetsa ntchito yolimbana ndi chotupa mumitundu yanyama.  

Mayesero a Phase I/II ndi chizindikiro chotseguka, magawo awiri akukwera kwa mlingo ndi kafukufuku wokulirapo wopangidwa kuti afotokoze zachitetezo ndi kulolera, kufufuza zolosera zam'tsogolo ndikuwunika zochitika zoyambira za JBI-802 mwa opitilira 100 omwe ali ndi zotupa zolimba kwambiri. Zambiri pazachipatala zitha kupezeka pa NCT05268666.

Hari S Bhartia, Wapampando wa Jubilant Therapeutics Inc. adagawana nawo chilengezocho, "Tachokera pakupeza mankhwala osokoneza bongo kupita ku dosing wamunthu. Tikuyembekezera kusintha miyoyo ya odwala. Ukadaulo wathu pakupanga mankhwala opangidwa ndi kapangidwe kake komanso chemistry yamankhwala umatithandiza kupanga njira zochiritsira zolondola komanso zotsogola kwambiri. ”

Syed Kazmi, Chief Executive Officer, Jubilant Therapeutics Inc. adati, "JBI-802, imasintha bwino zolinga ziwiri zovomerezeka za oncology zokhala ndi mgwirizano wofanana komanso wachangu pa / off kuwonetsa kinetics, zomwe zimatsogolera ku synergistic anti-chotupa ndikuchepetsa chiopsezo cha thrombocytopenia. Uyu ndiye woyamba kupangidwa mkati mwathu kuti alowe mu chitukuko chachipatala. Mapulogalamu ena opita patsogolo akuphatikiza oral brain penetrant inhibitor ya PRMT5, JBI 778, ndi oral brain penetrant PDL1 inhibitor, JBI 2174, yamakhansa amisala pakati pa ena.

Ponena za wolemba

Avatar ya Linda Hohnholz

Linda Hohnholz

Mkonzi wamkulu kwa eTurboNews zochokera ku eTN HQ.

Amamvera
Dziwani za
mlendo
0 Comments
Zolowetsa Pamakina
Onani ndemanga zonse
0
Mukufuna malingaliro anu, chonde yankhani.x
Gawani ku...